Your browser doesn't support javascript.
loading
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease.
He, Qing; Dou, Xuelin; Liu, Yang; Wen, Lei; Wang, Fengrong; Peng, Nan; Gong, Lizhong; Li, Yue; Lu, Yao; Wang, Liru; Zhang, Xiaohui; Huang, Xiaojun; Lu, Jin.
Afiliación
  • He Q; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Dou X; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Liu Y; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Wen L; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Wang F; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Peng N; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Gong L; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Li Y; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Lu Y; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Wang L; Department of Hematology, Fu Xing Hospital, Capital Medical University, Beijing, 100038, China.
  • Zhang X; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Huang X; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China.
  • Lu J; National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Peking University People's Hospital, Beijing, 100044, China. jin1lu@sina.com.
Ann Hematol ; 102(10): 2857-2864, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37436471
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraproteinemias / COVID-19 / Enfermedades Hematológicas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: Asia Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraproteinemias / COVID-19 / Enfermedades Hematológicas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Humans País/Región como asunto: Asia Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China